What would be the main indications for opting for biosimilars over an original biologic, outside of insurance barriers?

Topics: Medical Oncology • Biologic Therapy/Immunobiology • Rheumatology • Hematology • General Rheumatology • Biologics

Are there any instances where you would prefer a biosimilar rather than the reference product?

Answer from: at Community Practice

A timely question, as we head to 2023! The only reason to use biosimilars is for the broad purpose of resource stewardship. There isn't a medical reason to prefer a biosimilar over a reference product (or vice versa), because if a product were found to have a significantly different therapeutic effe...

Comments

at Arthritis Associates
I have had patients who responded differently to g...

Answer from: at Community Practice

For those interested, there is an upcoming webinar by the Arthritis Foundation discussing the usage of biosimilars in inflammatory arthritis. It is on 11/9/2022, 6-7PM ET. Further details at the link below: https://www.arthritis.org/events/webinars/upcoming-webinars This may provide further inform...

Comments

at Genesis HealthCare System
If you are unable to attend the webinar this is a ...

Related Questions